https://orcid.org/0000-0002-9856-7181
References
- Al-Momany, N.H., et al., 2019. Analysis of factors that interrupt with INR control in the first anticoagulation clinic monitoring Jordanian patients. Clinical and Applied Thrombosis/Hemostasis, 25, 107602961987025–1076029619870252.
- Amano, H., et al., 2017. Efficacy and safety of triple therapy and dual therapy with direct oral anticoagulants compared to warfarin. International Heart Journal, 58 (4), 570–576.
- Dean, L., 2012. Warfarin Therapy and VKORC1 and CYP Genotype. Medical Genetics Summaries. Bethesda (MD).
- Deaton, J. G., and Nappe, T. M., 2019. Warfarin Toxicity. StatPearls. Orange Park Medical Center. Treasure Island (FL): StatPearls Publishing.
- Denas, G., et al., 2009. Effectiveness and safety of a management protocol to correct over-anticoagulation with oral vitamin K: a retrospective study of 1,043 cases. Journal of Thrombosis and Thrombolysis, 27 (3), 340–347.
- Dharmarajan, L., and Dharmarajan, T.S., 2008. Prescribing warfarin appropriately to meet patient safety goals. American Health & Drug Benefits, 1 (6), 26–32.
- Feskanich, D., et al., 1999. Vitamin K intake and hip fractures in women: a prospective study. The American Journal of Clinical Nutrition, 69 (1), 74–79.
- Fihn, S.D., et al., 1993. Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group. Annals of Internal Medicine, 118 (7), 511–520.
- Geçmen, Ç., et al., 2016. Case images: Massive liver hematoma secondary to overdose of warfarin treatment. Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir, 44 (6), 530.
- Goldsmith, I., Turpie, A.G.G., and Lip, G.Y.H., 2002. Valvar heart disease and prosthetic heart valves. BMJ (Clinical Research ed.), 325 (7374), 1228–1231.
- Heffler, E., et al., 2016. A bloody mess: an unusual case of diffuse alveolar hemorrhage because of warfarin overdose. American Journal of Therapeutics, 23 (5), e1280–e1283.
- Hou, S.W., et al., 2008. Sonographic diagnosis of spontaneous intramural small bowel hematoma in a case of warfarin overdose. Journal of Clinical Ultrasound, 36 (6), 374–376.
- Hurley, B., et al., 2008. Using Lean Six Sigma® Tools to compare INR measurements from different laboratories within a community. Advances in Patient Safety: New Directions and Alternative Approaches (Vol. 3: Performance and Tools), 1–11.
- Levine, M., et al., 2014. Warfarin overdose: a 25-year experience. Journal of Medical Toxicolog: official Journal of the American College of Medical Toxicology, 10 (2), 156–164.
- Macedo, A.F., et al., 2015. Determinants of oral anticoagulation control in new warfarin patients: analysis using data from Clinical Practice Research Datalink. Thrombosis Research, 136 (2), 250–260.
- Matthews, S.S., Ringeisen, A.L., and Wedro, B., 2014. Intentional overdose of warfarin in an adult: anticoagulant reversal in the ED. The American Journal of Emergency Medicine, 32 (9), 1150.e1–e2.
- Palareti, G., et al., 1996. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). The Lancet, 348 (9025), 423–428.
- Petitti, D.B., Strom, B.L., and Melmon, K.L., 1989. Prothrombin time ratio and other factors associated with bleeding in patients treated with warfarin. Journal of Clinical Epidemiology, 42 (8), 759–764.
- Wysowski, D.K., Nourjah, P., and Swartz, L., 2007. Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action. Archives of Internal Medicine, 167 (13), 1414–1419.
- Xu, Y., et al., 2017. Direct oral anticoagulant- or warfarin-related major bleeding: characteristics, reversal strategies, and outcomes from a multicenter observational study. Chest, 152 (1), 81–91.
- Yetkin, U., Karabay, O., and Onol, H., 2004. Effects of oral anticoagulation with various INR levels in deep vein thrombosis cases. Current Controlled Trials in Cardiovascular Medicine, 5 (1), 1.